NEPHROCARE Share Price Performance
₹138.00
-78.45 (-36.24%)
Price ₹138.00
Share Price₹138.00
Nephro Care India Limited's (NSE:NEPHROCARE) Shares Climb 30% But Its Business Is Yet to Catch Up
Aug 08
Nephro Care India Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
NEPHROCARE Community Narratives
There are no narratives available yet.
Recent NEPHROCARE News & Updates
Nephro Care India Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 2.21
- Gross Margin
- 54.57%
- Net Profit Margin
- 7.91%
- Debt/Equity Ratio
- 0%
Nephro Care India Limited Competitors
Snowflake Analysis
About NEPHROCARE
- Founded
- 2014
- Employees
- 334
- CEO
- WebsiteView website
Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilitation programs. Its clinics provides renal transplant, urology, vascular surgery, carepath diagnostics, digital radiology, cardiology, OT facilities, women welfare services. In addition, the company offers pulmonary function test, EMG/NCV-testing, uroflowmetry, EEG, polysomnography, and retinal screening services. The company was incorporated in 2014 and is based in Kolkata, India.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Indian Market Performance
- 7 Days: 1.5%
- 3 Months: -1.7%
- 1 Year: -4.7%
- Year to Date: 0.7%
The market has climbed 1.5% in the last 7 days, lead by the Financials sector with a gain of 2.3%. Over the past year the market is down 4.7%. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›